Total pancreatectomy with autologous islet cell transplantation (TP with AIT) is an effective treatment for chronic pancreatitis patients with severe abdominal pain. Body mass index (BMI) of the pancreatic donor is proven to be a useful predictor for islet isolation and transplantation outcomes in allogenic islet transplantation. However, the association between BMI and islet isolation outcome and/or metabolism after AIT was previously unclear. Twelve patients who received TP with AIT at our hospital were included in this study. All pancreata were preserved with both pancreatic ductal injection and oxygen-charged static two-layer method using ET-Kyoto solution. The cohort was divided into two groups: low BMI group (BMI < 23 kg/ m 2 , n = 5) and high BMI group (BMI ≥ 23, n = 7). The high BMI group had a significantly higher islet yield per gram than the low BMI group both in pancreas postdigestion and in final product (postdigestion: 7330 ± 539 vs. 3509 ± 563 IE/g; p < 0.001; final product: 6555 ± 585 vs. 3476 ± 546 IE/g; p = 0.004). For islet yield in final product per patient body weight, the high BMI group also had significantly higher islet yield than the low BMI group (7997 ± 779 vs. 4175 ± 750 IE/kg, p = 0.007). Insulin independence rate in the high BMI group (71%) was also higher than that low BMI group (40%), but it did not reach statistical significance. Pancreata from patients with higher BMI could obtain higher islet yield in the setting of autologous islet cell transplantation for chronic pancreatitis.
INTRODUCTION
sota reported that fibrosis and acinar atrophy inversely correlated with islet yield in their pediatric cohort (19) . The same group also showed that body weight and fast-Predicting islet isolation results is important to identifying suitable donors for islet transplantation. Most pre-ing blood glucose could predict islet yield in pediatric patients with chronic pancreatitis (3). vious reports on factors that affect human islet isolation were based on data using deceased donors, which aimed
In this study we examined whether BMI is an effective predictor for islet isolation from a chronic pancreati-for successful islet allotransplantation for patients with type 1 diabetes (4,7,8, 13,15,18,20,22,23,32,33,36,40,42, tis pancreas. 47). These studies showed a high donor body mass in-MATERIALS AND METHODS dex (BMI) improved islet yields.
Patients Total pancreatectomy and autologous islet cell transplantation is a treatment option for chronic pancreatitis We started performing autologous islet transplantation for patients with chronic pancreatitis in November with severe abdominal pain (6, 11, 38) . Predicting islet isolation results is also important in identifying suitable 2006. Beginning in December 2007, we adapted novel pancreas preservation and isolation methods resulting in patients. However, there is limited information on the effects of BMI on the outcome of islet isolation for au-excellent islet isolation outcomes from brain-dead donors (29, 35) . Because our islet isolation methods sub-tologous islet transplantation. The University of Minne-314 TAKITA ET AL. stantially changed in December 2007, we only analyzed dide staining (2). The viability was calculated by averaging the viability of 50 islets. data after this time.
Twelve patients who fulfilled the following criteria Transplantation were included in this study: (i) clinically diagnosed chronic pancreatitis with intractable pain, (ii) received Isolated islets were infused into the portal vein via total pancreatectomy with islet autotransplantation from the mesenteric vein with heparin (70 U/kg body weight) December 2007 to October 2009 at Baylor University over 30-60 min while the patient was under general an-Medical Center (Dallas, TX), (iii) infused islets that esthesia. During islet infusion, portal vein pressure was were isolated as described below. This study was apmonitored intermittently. If portal vein pressure was proved by institutional review board at Baylor Research higher than 22 mmHg the infusion of islets was stopped Institute (Dallas, TX) and written informed consent was and then restarted when portal vein pressure was reobtained from all patients included in this study.
duced.
Image Studies Before Transplantation Islet Preparation
Imaging studies including endoscopic retrograde cho-Immediately after total pancreatectomy, chilled ETlangiopancreatography (ERCP) and endoscopic ultraso-Kyoto solution (Otsuka Pharmaceutical Factory Inc., nography (EUS) at pretransplantation period were re-Naruto, Japan) was injected through a cannula inserted viewed. ERCP images were classified according to the into the main pancreatic duct as previously described for Cambridge classification: "Normal" (scored as 0) to ductal injection (16, 26, 27, 35) . The pancreas was pre-"Marked" (scored as 4) (1,43). Previous reports showed served using the oxygen-charged static two-layer method the EUS is useful to evaluate the diagnosis and severity (ET-Kyoto solution/oxygenated PFC) (30). Liberase of chronic pancreatitis (5, 12, 17, 46) . EUS criteria in-MTF with thermolysin (Roche, Indianapolis, IN) or colcluded hyperechoic foci, hyperechoic strands, parenchylagenase NB with neutral proteases (Serva Electrophoremal lobularity, irregular main pancreatic duct margins, sis GMbH, Heidelberg, Germany) was infused into the hyperechoic main pancreatic duct margins, visible side main pancreatic duct (Table 1) (28) . Pancreas digestion branches budding, main pancreatic duct dilatation, shadwas performed using the modified Ricordi method (37) . owing calcifications and cysts, and the presence of four If pellet volume was larger than approximately 15 ml, or more criteria was used for diagnosis of chronic panislets were purified with the COBE 2991 cell processor creatitis (9,41). (CaridianBCT, Inc; Lakewood, CO) with continuous density gradient centrifugation (26). The final prepara-Assessment of Transplanted Islet Function tion of islets was assessed for its yield and purity using dithizone staining (2 mg/ml; Sigma Chemical Co., St.
Insulin independence was defined as 2 weeks or longer of no exogenous insulin with good glycemic con-Louis, MO). The islet yield was converted into a standard number of islet equivalents (IEQ, diameter stand-trol by capillary glucose measurements, both available from daily diaries according to the report from Collabo-ardizing to 150 µm) (21) . Islet viability in final product was evaluated with fluorescein diacetate/propidium io-rative Islet Transplant Registry (CITR) (10). Blood glu- cose was controlled with continuous intravenous insulin were met, the islet function was defined as "partial function." infusion in intensive care unit immediate after surgery, followed by subcutaneous insulin injection therapy to maintain the following goal: fasting blood glucose <126 Pain Assessment mg/dl or HbA1 C ≤ 6.5%. HbA1 C was measured at 1 Pain was scored according to visual analogue scales month after transplantation.
(VAS) from 0 (no pain) to 10 (severe pain). Opioid Transplanted islet function was assessed by C-peptide doses for pain control were also collected from the difand secretory unit of islet transplant objects (SUITO) ferent prescriptions and converted to morphine equivaindex. The highest value of fasting C-peptide in multiple lent doses according to published data (14). samples from postoperative days 3 to 10 for each case was evaluated. Because serum C-peptides might be re-Histology and Immunohistochemistry leased from injured islets within 48 h after islet transplantation, we excluded the C-peptide value on post-Biopsy specimens from a pancreatic head were taken in one case with severe chronic pancreatitis (49-year-old operative days 1 and 2 for this assessment. SUITO index, which has been shown to be a good clinical pa-female). For control, biopsy specimens from a normal pancreas were also taken (48-year-old female). The sam-rameter for engrafted islet function in previous publications, was calculated using the following formula: 1500 × ples were embedded in OCT compound (Tissue Tek, Torrance, CA) and stored at −80°C until sectioning. Sec-fasting C-peptide level (ng/ml)/[fasting blood glucose (mg/dl) − 63] (25, 31) .
tions (9 µm) of embedded specimens were taken and stained for insulin (1:75 dilution, Abcam, Cambridge, When the value of C-peptide was below the detective level of the assay (0.1 ng/ml), the islet function was de-MA) using standard immunohistochemical (IHC) techniques. After incubation with horseradish peroxidase fined as "no function." When a patient achieved insulin independence, the islet function was defined as "full (HRP)-onjugated secondary antibody, staining was visualized using diaminobenzidine (DAB) and the sections function." When neither of the above two conditions were counterstained with hematoxylin. Additional sec-were done using a two-sided Fisher's exact test. Mann-Whitney U-test was used for nonparametric parameters: tions were stained with hematoxylin and eosin (H&E).
pain score, score of Cambridge classification for ERCP, number of positive EUS criteria, and distention score.
Statistical Analysis
Correlations were evaluated using Spearman's coefficients. A receiver operating characteristic (ROC) curve Data analyses were performed using SPSS 15.0 for Windows (SPSS, Chicago, IL). Patients were divided was plotted to determine the cut off value of BMI for islet yields. A two-sided value of p < 0.05 was consid-into the following two groups according to BMI (kg/ m 2 ): low BMI group (BMI < 23) and high BMI group ered statistically significant. Values are expressed as mean ± SE, except for nonparametric parameters, which (BMI ≥ 23). The difference of means was tested by Student' t-test and comparisons of rates between groups are expressed as median and range. 
RESULTS
group had significantly poorer scores of distension when compared with the high BMI group (p = 0.04). Islet Patient Characteristics yield (IE) and islet yield per pancreas weight (IE/g) at both postdigestion and final product had significant dif-Patient characteristics before transplantation are shown in Table 2 . All patients were administered a regu-ferences between the two groups. Total islet yield per patient body weight (IE/kg) was also significantly dif-lar narcotic medication. There were no diabetic patients before transplantation in this cohort. The low BMI group ferent among the two groups (p = 0.007). In order to eliminate the effect of previous operations we eliminated had significantly higher scores of severity of pancreatitis assessed by both ERCP (p = 0.007) and EUS (p = 0.02) two cases with previous operations and re-analyzed the data. Even excluding the two cases with past history of than the high BMI group. Mean duration of symptoms in the low BMI group were longer than the high BMI pancreatic operation from the low BMI group, there were still significant differences in islet yield (IE), islet group, which did not reach statistical significance. There was a significant correlation between BMI and EUS yield per pancreas weight (IE/g), and islet yield per patient body weight (IE/kg) at both postdigestion and final score (Spearman's coefficient r = −0.928, p = 0.008), although there was no significant correlation with duration product between the low-and high BMI groups (p < 0.05) (Table 4 ). There were no statistical differences in of symptoms (r = −0.169, p = 0.64) and ERCP (r = −0.544, p = 0.16).
purity and viability. There was a significant correlation between BMI and islet yield in final product (r = 0.74, Outcome of Islet Isolation p = 0.006) and at postdigestion (r = 0.83, p = 0.001) (Fig. 1 ). There were no significant differences in pancreas weight and cold ischemia time (Table 3) 
. The low BMI
The rate of isolated islet size of 100-150 µm at post- kg were 100% when cut off value was BMI 23 (area under the curve 1.0 ± 0.0, p = 0.007) (Fig. 2) .
Metabolic Outcome
Follow-up period in the low BMI group was significantly shorter than the high BMI group (p = 0.02) ( Table  6 ). All patients maintained graft function assessed by positive C-peptide. Insulin independence rate and average SUITO index in the high BMI group was higher than in the low BMI group, but it did not reach statistical significance, whereas the highest fasting C-peptide in the high BMI group was significantly higher than the low BMI group (p = 0.01). Average HbA1 C in both groups remained less than 6.5% and there was no significant difference between two groups (p = 0.74).
Histology in the Low BMI Group
The majority of exocrine tissue was already destroyed in pancreas with severe chronic pancreatitis as seen in H&E staining (Fig. 3A ) and insulin staining Figure 2 . ROC curve of BMI for islet yield >5,000 IE/kg. (Fig. 3B ) compared to normal pancreas (Fig. 3C, D) .
Each number in the graph shows BMI at the point on ROC This patient had the lowest islet yield per body weight curve. BMI 23 is the most appropriate for cut off value to determine islet yield >5,000 IE/kg.
(2,559 IE/kg) and low BMI (BMI 19.2).
DISCUSSION
The retrospective study presented here supports an digestion in the high BMI group was significantly higher than the low BMI group (p = 0.04), although that of association among BMI, islet yields, and clinical outcomes in autologous islet cell transplantation for patients 300-350 µm in the high BMI group was significantly lower than the low BMI group (p = 0.05) (Table 5) .
with chronic pancreatitis. This is the first report to mention the association between BMI and islet isolation and Validation of the Cut Off Value of BMI metabolic outcome for autologous islet cell transplantation. This study showed that patients in the high BMI Previous large cohort studies showed that islet yields in final product per patient body weight (IE/kg) were group had better islet isolation and autologous islet cell transplantation outcomes, similar to allogeneic islet significantly correlated with graft function; in patients with more than 5,000 IE/kg, 86% had graft function and transplantation findings previously reported (23, 33, 42) . For allogeneic islet isolation, pancreas distension is 63% remained insulin independent 1 year after transplant (44) . Herein, we validated cut off value of BMI usually excellent because only pancreata of reasonable quality were selected for islet isolation. However, in the for islet yield in final product per patient body weight more than 5,000 IE/kg using ROC analysis. Both sensi-case of auto-islet transplantation, patients were selected because of severity of abdominal pain irrespective of the tivity and specificity to determine islet yield > 5,000 IE/ status of pancreatitis. Therefore, we encountered low-curement, the pancreas is immediately chilled by the perfusion of cold preservation solution. Conversely, for quality pancreata for auto-islet transplantation.
Recently, we implemented novel methods for pan-autologous islet transplantation, the pancreas is procured without perfusion of cold preservation solution; there-creas procurement and islet isolation, which were originally developed for allogeneic islet cell transplantation fore, the pancreas suffers from warm ischemic injury. Because warm ischemic injury of more than 30 min had using a non-heart-beating donor pancreas (29) , into autologous islet cell transplantation for patients with a significant impact on islet isolation (22), minimizing warm ischemic time is critical. We postulated that ductal chronic pancreatitis to maximize islet yield and graft function. In order to avoid the effect of differences in injection of chilled ET-Kyoto solution minimized warm ischemic time for autologous islet isolation and trans-pancreas procurement and islet isolation methods, only cases in which the novel methods were fully performed plantation. It was shown that two-layer method can alleviate warm ischemic injury (24). However, because av-were included in this study. These new methods including ductal injection with ET-Kyoto solution and two-erage cold ischemic time was only 45 min in this study, the effect of the two-layer method is uncertain. layer method with oxygenated perfluorochemical (PFC) could obtain significantly higher islet yields than the In this study, the low BMI group had significantly higher scores in clinical image studies for severity of previous methods used (34) . For cadaveric pancreas pro-pancreatitis suggesting late stage inflammation. Pre-though advanced pancreatitis eventually destroyed islets, which is definitely a disadvantage. viously it was demonstrated that pancreatic fibrosis was associated with poor islet yield (22) and number of EUS There are some limitations in this study: small number of cohort, retrospective design, and relatively short criteria was well associated with histological findings (45). In this study, fibrotic change was observed in pa-follow-up periods. In addition, there is a possibility that image scores on EUS and ERCP were confounding fac-tients with lowest islet yield per body weight. Lower BMI might be associated with inflammatory change of tors to the association among BMI, islet yields, and clinical outcomes in autologous islet cell transplantation. pancreas. In addition, in this study pancreas distension was significantly worse in the low BMI group. This dif-Further investigations are needed to determine the clinical impact of BMI on long-term graft function. In sum-ficulty in distension is most likely due to fibrosis and rigidity because of severe pancreatitis. Damage to the mary, higher BMI was associated with greater islet yields and better islet function. BMI was also associated pancreas due to inflammation plus distension difficulty due to rigidity in the low BMI group should be the main with the score of clinical imaging studies such as ERCP and EUS, which suggests that patients with lower BMI reason for lower islet yield. Symptom duration in patients with the low BMI was longer than those with high might have a more advanced phase of chronic pancreatitis. Therefore, BMI seems to be one candidate to predict BMI, although it was not statistically significant. Both patients with a past history of pancreas surgery were autologous islet transplantation success. included in the low BMI group, which also might sug-ACKNOWLEDGMENTS: This work was supported in part by gest that the low BMI group had advanced stage of creatitis had poor digestive enzymes, those patients REFERENCES might lose their body weight due to malnutrition. This malnutrition might be another reason for poor islet yield
